Iliac Stent Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Iliac stents are small mesh tubes implanted in the iliac arteries to restore blood flow in patients with peripheral artery disease (PAD), which causes narrowing or blockage in the major arteries supplying the lower body. The global market encompasses both balloon-expandable stents, which are precisely positioned during deployment, and self-expanding stents that conform to vessel anatomy. These devices are critical in treating aortoiliac occlusive disease and maintaining long-term patency in compromised arteries.

• •Market addresses peripheral artery disease in iliac arteries serving the pelvis and lower extremities
• •Products include balloon-expandable bare metal, covered, and self-expanding stent variants
• •Procedures typically performed via minimally invasive endovascular techniques

The rising global incidence of peripheral artery disease, driven by increasing prevalence of diabetes, obesity, and smoking, directly expands the patient pool requiring iliac interventions. An aging worldwide population further amplifies demand, as PAD risk increases significantly with age. Technological innovations producing thinner strut profiles, improved deliverability, and bioactive coatings enhance clinical outcomes and broaden the range of treatable anatomies.

• •Growing burden of diabetes and cardiovascular risk factors elevates PAD prevalence globally
• •Demographic shift toward older populations increases procedural volumes
• •Miniaturization and material science advances improve stent flexibility and radial strength

Product segmentation distinguishes balloon-expandable stents, favored for precise deployment in ostial and calcified lesions, from self-expanding stents that accommodate vessel movement in flexible anatomical segments. Covered stent grafts add an endothelial lining to address complications like restenosis and aneurysm formation. Geographically, North America and Europe currently account for the largest market shares due to established healthcare infrastructure, high procedure volumes, and favorable reimbursement frameworks.

• •North America leads in market share, supported by advanced endovascular capabilities and broad insurance coverage
• •Europe represents a significant market with strong adoption of minimally invasive vascular interventions
• •Asia-Pacific is projected to grow fastest as healthcare access expands and procedural techniques disseminate

What are the recent trends and outlook?

The market is gradually shifting toward bioresorbable scaffold technology and drug-eluting stent designs aimed at reducing long-term restenosis rates while preserving vessel function. Integration of imaging guidance and robotics may further enhance procedural precision and outcomes. As the global population ages and minimally invasive techniques gain acceptance in emerging markets, sustained growth is expected throughout the forecast horizon, with innovation cycles driving periodic market resets.

• •Drug-eluting and bioresorbable technologies are under active development to address restenosis concerns
• •Hybrid procedures combining multiple endovascular techniques are gaining clinical adoption
• •Emerging markets in Asia-Pacific, Latin America, and the Middle East represent expanding opportunities